+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fusion Protein"

Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 51 Pages
  • Global
From
Rett Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Rett Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 110 Pages
  • Global
From
Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 51 Pages
  • Global
From
Proteomics - Technologies, Markets and Companies - Product Thumbnail Image

Proteomics - Technologies, Markets and Companies

  • Report
  • November 2021
  • 656 Pages
  • Global
From
Bioinformatics Tools for Pharmaceutical Drug Product Development. Edition No. 1 - Product Thumbnail Image

Bioinformatics Tools for Pharmaceutical Drug Product Development. Edition No. 1

  • Book
  • February 2023
  • 448 Pages
Contemporary Accounts in Drug Discovery and Development. Edition No. 1 - Product Thumbnail Image

Contemporary Accounts in Drug Discovery and Development. Edition No. 1

  • Book
  • April 2022
  • 480 Pages
ADME and Translational Pharmacokinetics / Pharmacodynamics of Therapeutic Proteins. Applications in Drug Discovery and Development. Edition No. 1 - Product Thumbnail Image

ADME and Translational Pharmacokinetics / Pharmacodynamics of Therapeutic Proteins. Applications in Drug Discovery and Development. Edition No. 1

  • Book
  • January 2016
  • 472 Pages
Therapeutic Fc-Fusion Proteins. Edition No. 1 - Product Thumbnail Image

Therapeutic Fc-Fusion Proteins. Edition No. 1

  • Book
  • February 2014
  • 400 Pages
Plants as Bioreactors for Industrial Molecules. Edition No. 1 - Product Thumbnail Image

Plants as Bioreactors for Industrial Molecules. Edition No. 1

  • Book
  • March 2023
  • 544 Pages
Loading Indicator

The Fusion Protein market is a subset of the Drug Discovery market, focusing on the development of fusion proteins for therapeutic use. Fusion proteins are created by combining two or more proteins, which can be used to increase the stability, solubility, and bioavailability of the proteins. Fusion proteins can also be used to target specific tissues or organs, or to increase the half-life of a protein. Fusion proteins are used in a variety of therapeutic areas, including oncology, immunology, and metabolic diseases. They are also used in the development of vaccines and diagnostics. Companies in the Fusion Protein market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more